Final Analysis of DEEPER Trial in RAS/BRAF Wild-Type Metastatic CRC

◆ TRIAL DATA

The DEEPER trial presents final analysis of long-term survival outcomes comparing modified-FOLFOXIRI plus cetuximab versus bevacizumab in patients with RAS and BRAF wild-type metastatic colorectal cancer. (Journal of Clinical Oncology)